We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZETA icon
101
Zeta Global
ZETA
$6.42B
$7.27M 0.11%
+535,787
New +$9.57M
VERA icon
102
Vera Therapeutics
VERA
$2.3B
$7.21M 0.11%
300,000
+121,717
+68% +$3.91M
BILL icon
103
BILL Holdings
BILL
$4.68B
$7.18M 0.11%
156,447
+32,156
+26% +$2.16M
HUBS icon
104
HubSpot
HUBS
$10.1B
$6.88M 0.1%
12,037
-31,444
-72% -$22.1M
CNTA
105
DELISTED
Centessa Pharmaceuticals
CNTA
$6.73M 0.1%
+468,000
New +$7.66M
ORLY icon
106
O'Reilly Automotive
ORLY
$76.2B
$5.94M 0.09%
62,235
-5,490
-8% -$478K
MUSA icon
107
Murphy USA
MUSA
$9.9B
$5.83M 0.09%
+12,408
New +$5.89M
CPNG icon
108
Coupang
CPNG
$29.4B
$5.8M 0.09%
264,375
-92,497
-26% -$2.15M
CMG icon
109
Chipotle Mexican Grill
CMG
$42.7B
$5.72M 0.09%
114,000
+14,131
+14% +$769K
PFE icon
110
Pfizer
PFE
$149B
$5.37M 0.08%
+211,740
New +$5.54M
BBY icon
111
Best Buy
BBY
$16.9B
$5.31M 0.08%
72,144
-15,533
-18% -$1.28M
PDSB icon
112
PDS Biotechnology
PDSB
$41.8M
$5.26M 0.08%
+4,419,000
New +$6.29M
LOW icon
113
Lowe's Companies
LOW
$122B
$5.17M 0.08%
22,147
-33,010
-60% -$8.12M
BSX icon
114
Boston Scientific
BSX
$71.4B
$5.02M 0.08%
+49,762
New +$5.01M
SHW icon
115
Sherwin-Williams
SHW
$88.2B
$4.89M 0.07%
+14,018
New +$4.92M
MDCX
116
Medicus Pharma
MDCX
$17.4M
$4.71M 0.07%
+1,266,000
New +$3.97M
VNRX icon
117
VolitionRx Ltd
VNRX
$9.23M
$4.68M 0.07%
410,322
-13,773
-3% -$164K
LVS icon
118
Las Vegas Sands
LVS
$29.9B
$4.67M 0.07%
120,822
-28,792
-19% -$1.27M
EW icon
119
Edwards Lifesciences
EW
$51.5B
$4.57M 0.07%
62,995
-106,834
-63% -$7.65M
ARAY icon
120
Accuray
ARAY
$33.8M
$4.54M 0.07%
2,536,000
+1,300,000
+105% +$2.72M
MGNI icon
121
Magnite
MGNI
$3.49B
$4.44M 0.07%
+389,000
New +$6.2M
VRNA
122
DELISTED
Verona Pharma
VRNA
$4.33M 0.06%
+68,201
New +$4.08M
LEN icon
123
Lennar Class A
LEN
$20.4B
$4.02M 0.06%
+35,000
New +$4.37M
FERG icon
124
Ferguson
FERG
$49.1B
$3.85M 0.06%
+24,000
New +$4.16M
VRCA icon
125
Verrica Pharmaceuticals
VRCA
$92.1M
$3.79M 0.06%
856,740
-35,360
-4% -$229K
3 4
5
6 7

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.